Law firms solicit shareholders over Element, Crinetics and Solstice deals

Law firms solicit shareholders over Element, Crinetics and Solstice deals

Monteverde and Halper Sadeh issued attorney advertisements on the proposed Element Solutions-Solstice transaction, Crinetics' sale to Vertex, and Solstice's merger with Element, seeking shareholder contacts and citing possible deal-related claims.

Fact Check
The two GlobeNewswire releases are the primary attorney advertisements themselves. The Monteverde release confirms investigations into the Element Solutions-Solstice deal, Crinetics' sale to Vertex, and Solstice's merger with Element, seeking shareholder contacts. The Halper Sadeh release confirms parallel investigations into the same ESI, CRNX, and SOLS transactions, citing possible insider benefits and deal-restriction claims. The underlying Crinetics-Vertex $85.00/share deal is independently corroborated by Crinetics' own press release. All elements of the claim are supported.
    Reference123
Summary

Monteverde & Associates PC and Halper Sadeh LLC issued July 2026 attorney advertisements seeking shareholder contacts regarding proposed transactions involving Element Solutions, Crinetics Pharmaceuticals and Solstice Advanced Materials. Both firms cited Element Solutions' proposed sale to Solstice for $10.00 in cash plus 0.500 Solstice shares per Element share, with Element shareholders expected to own about 44% of the combined company at closing; Crinetics' proposed sale to Vertex Pharmaceuticals for $85.00 per share in cash; and Solstice's merger with Element Solutions. Halper Sadeh said it is investigating potential federal securities law violations or breaches of fiduciary duties and may seek increased consideration, additional disclosures or other relief, while Monteverde said shareholders could seek more information at no cost or obligation as part of a broader set of merger and sale probes.

Terms & Concepts
  • fiduciary duties: Legal obligations of corporate directors and officers to act in shareholders' best interests.
  • additional disclosures: Extra information about a proposed transaction that shareholders or their counsel may seek from a company.
  • merger: A transaction in which companies combine or one company is acquired by another.